跳至主要内容
临床试验/CTRI/2023/05/052987
CTRI/2023/05/052987尚未招募3 期

EFFICACY OF SHWADANSHTRADI GHANA VATI AS COMPARED TO TABLET CEFIXIME IN THE MANAGEMENT OF GARBHINI MUTRAKRICCHRA (URINARY TRACT INFECTION DURING PREGNANCY) â?? RANDOMISED CONTROLLED CLINICAL TRIA

All india institute of ayurveda , New delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Pregnant women (Primigravida or Multi gravida) with age of 20 to 35 years who are
  • attending AIIA Hospital for Ante natal care with gestational age from 16 weeks to
  • 36 weeks with signs & symptoms of Mutrakricchra (UTI during Pregnancy) - Sadah
  • Mutrata (Burning Micturition), Saruja Mutrata (Painful Micturition), Muhur muhur mutrata (Frequency Micturition), Adho udar shola (Lower abdominal pain).
  • Pregnant women with asymptomatic Bacteriurea. (Patients those who are not having
  • any signs & symptoms of UTI, but there Lab reports of Urine analysis and Urine
  • culture are suggestive of UTI.)
  • Pregnant women willing for trial.

排除标准

  • All non-pregnant women with UTI.
  • Postpartum UTI.
  • Pre-existing congenital renal tract anomalies.
  • Pregnant Women with chronic renal disorders, Polycystic kidneys, Hydronephrosis,
  • Impaired renal function.
  • Pregnant women who need hospitalization for urinary problem with uterine
  • discomfort with urine analysis and urine culture report suggestive of UTI.
  • Malignancy of Urinary Tract.
  • Immuno-compromised patients.
  • Pregnant women with severe anemia Hb < 7 gm/dl.
  • Pregnancy complicated with other medical disorders.
  • Any complication in pregnancy like Polyhydroamnios, Placental abnormalities.
  • Pregnancy induced hypertension.
  • Gestational Diabetes Mellitus.
  • Pregnancy with thyroid dysfunction, High Risk Pregnancy

研究者

发起方
All india institute of ayurveda , New delhi

相似试验